1. EachPod

Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management

Author
Dr. Neil Love
Published
Mon 28 Jul 2025
Episode Link
https://oncologytoday.captivate.fm/episode/5440-oncologytoday25-mbc-1

Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, discusses the efficacy and safety of approved and investigational antibody-drug conjugates for endocrine-resistant HR-positive and triple-negative metastatic breast cancer. 

CME information and select publications here.

Share to: